FLÜSSIGE DOSIERFORMEN SÄURELABILER ARZNEIMITTEL

Patent europeic · EP1539156 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1539156
Numer da la dumonda
EP03763122
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
02-07-2003
Publitgà
15-06-2005
Concedì
12-12-2012
Stritgà
31-07-2018
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/4439 (2006.01)
A61K 9/08 (2006.01)
A61K 9/10 (2006.01)
A61K 9/58 (2006.01)
A61K 9/26 (2006.01)
Prioritad
US 190242 03.07.2002
Dumonda PCT
PCT/US2003/020875 02.07.2003
Publicaziun PCT
WO2004/004718 15.01.2004
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-02-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.02.2019

  2. 17-07-2014

    Adressa midada

    Representative
    BOHEST AG, Postfach 160, 4003 Basel → BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 17.07.2014

  3. 14-03-2013

    Represchentant inscrit

    Representative
    BOHEST AG, Postfach 160, 4003 Basel

    Published in Swissreg on 14.03.2013

  4. 12-12-2012

    Concedì

    Published in Swissreg on 12.12.2012

Partidas

Possessur

Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A Inc.

One Takeda Parkway, Deerfield, IL 60015, US

Represchentant

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventur

TANEJA, Rajneesh

Libertyville, IL 60048, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.